placebo group:placebo injection
Sponsors
Shanghai Skin Disease Hospital, West China Hospital of Sichuan University
Conditions
Plaque Psoriasishealthy person
Phase 1
Pharmacokinetics, Tolerability, Immunogenicity, Dose Increasing Safety and Evaluate of Preliminary Effect Clinical Trial for High dose of GR1501 injection (200mg, 300mg) in Patients With Plaque Psoriasis
RecruitingChiCTR1900025612
Start: 2019-08-28Updated: 2019-09-02
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-1894 in Healthy Subjects: A Randomised, Double-Blind, Placebo-Controlled Phase I Clinical Study
Active, not recruitingChiCTR2600120084
Start: 2026-03-17Updated: 2026-03-16